Home › Laryngeal Cancer
Laryngeal Cancer clinical trials recruiting in the U.S.
26 studies for Laryngeal Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Chicago, IL8 studies
- Milwaukee, WI8 studies
- Atlanta, GA8 studies
- Kansas City, MO7 studies
- St. Louis, MO7 studies
- Cincinnati, OH6 studies
- Richmond, VA6 studies
- Edison, NJ6 studies
- Baltimore, MD6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
- Portland, OR6 studies
- Overland Park, KS5 studies
- Kansas City, KS5 studies
- Cape Girardeau, MO5 studies
- Charleston, IL5 studies
- Joliet, IL5 studies
- Naperville, IL5 studies
- Cedar Rapids, IA5 studies
- Wausau, WI5 studies
- Stevens Point, WI5 studies
- Duluth, MN5 studies
- Danville, IL5 studies
- Oklahoma City, OK5 studies
- Champaign, IL5 studies
- Peoria, IL5 studies
- Bloomington, IL5 studies
- Lansing, MI5 studies
- Ann Arbor, MI5 studies
- Philadelphia, PA5 studies
- Omaha, NE5 studies
- Fargo, ND5 studies
- Queens, NY5 studies
- New York City, NY5 studies
- Irvine, CA5 studies
- Tampa, FL4 studies
- Flint, MI4 studies
- Erie, PA4 studies
- Columbus, OH4 studies
- Boston, MA4 studies
By state
- Arizona5 studies
- Arkansas5 studies
- California9 studies
- Colorado7 studies
- Connecticut3 studies
- Delaware3 studies
- Florida8 studies
- Georgia8 studies
- Idaho4 studies
- Illinois9 studies
- Indiana4 studies
- Iowa8 studies
- Kansas7 studies
- Kentucky3 studies
- Louisiana4 studies
- Maryland7 studies
- Massachusetts7 studies
- Michigan6 studies
- Minnesota7 studies
- Mississippi3 studies
- Missouri9 studies
- Montana5 studies
- Nebraska5 studies
- New Hampshire3 studies
- New Jersey7 studies
- New Mexico3 studies
- New York10 studies
- North Carolina8 studies
- North Dakota5 studies
- Ohio11 studies
- Oklahoma6 studies
- Oregon6 studies
- Pennsylvania9 studies
- South Carolina5 studies
- South Dakota3 studies
- Tennessee3 studies
- Texas5 studies
- Virginia7 studies
- Washington3 studies
- Wisconsin9 studies
Recently updated studies
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06589804Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07195734Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06980038BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Recruiting
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT06997068Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Recruiting
Ages 18 and older · All sexes · Updated Feb 10, 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Recruiting
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
Recruiting
Ages 18 and older · All sexes · Updated Nov 26, 2025 · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 22, 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RecruitingObservational study
Ages 21 to 90 · All sexes · Updated Sep 22, 2025 · NCT00900419From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.